Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

During the Trading Day
141.85 +0.77 / +0.55%
As of 4:05pm ET
Day’s Change
During After-Hours   Switch to standard view »
141.61 -0.2394 / -0.17%
Volume: 300.00

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Revenue and IncomeNet Revenues237.7M244.2M215.3M212.1M
Cost of Goods Sold40.3M40.7M39.6M37.5M
Depreciation And Amortization3.9M3.9M3.9M3.9M
Operating ExpensesGross Income193.5M199.6M171.8M170.7M
General Expenses34.2M46.1M37.4M42.8M
Research And Development12.8M23.9M14.5M18.7M
Total Operating Expenses78.4M90.6M80.9M84.1M
Non-Operating ExpensesOperating Income159.3M153.5M134.4M127.9M
Extraordinary Charge-------2.9M
Other Expenses8.6M32.9M-3.8M35.6M
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income170.9M189.5M133.8M164.0M
Income Taxes-28.2M-36.9M-30.1M-30.4M
Minority Interest-132.0K-26.0K-37.0K-139.0K
Discontinued Operations-126.0K-314.0K-31.0K-70.0K
Net Income142.5M152.3M103.6M133.3M
Shares To Calculate EPSShares To Calculate EPS42.8M42.8M42.8M42.8M
Shares To Calculate EPS Diluted42.8M42.8M42.8M42.8M
Earnings Per ShareEPS$3.33$3.56$2.42$3.11
EPS Diluted$3.33$3.56$2.42$3.11